MOORE CAPITAL MANAGEMENT, LP - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 2.16 and the average weighting 0.4%.

Quarter-by-quarter ownership
MOORE CAPITAL MANAGEMENT, LP ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$685,000
-66.8%
50,000
-83.3%
0.02%
-63.1%
Q4 2014$2,061,000
+27.2%
300,0000.0%0.06%
+71.1%
Q3 2014$1,620,000
-15.2%
300,0000.0%0.04%
-17.4%
Q2 2014$1,911,000
+107.7%
300,000
+500.0%
0.05%
+130.0%
Q3 2013$920,000
-29.9%
50,000
-33.3%
0.02%
-35.5%
Q2 2013$1,312,00075,0000.03%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$80,313,00015.61%
Opaleye Management Inc. 1,310,000$8,188,0003.42%
Camber Capital Management LP 5,405,235$33,783,0002.18%
IRONWOOD INVESTMENT MANAGEMENT LLC 471,516$2,947,0001.22%
HighVista Strategies LLC 807,100$5,044,0000.94%
JS Capital Management LLC 630,000$3,938,0000.94%
1492 Capital Management LLC 202,500$1,266,0000.92%
Palo Alto Investors LP 2,257,217$14,108,0000.78%
Geduld E E 185,100$1,157,0000.72%
Elk Creek Partners, LLC 1,592,527$9,953,0000.71%
View complete list of ARIAD PHARMACEUTICALS INC shareholders